NEW YORK, Sept. 20, 2018 /PRNewswire/ -- Bernstein Liebhard
LLP, a nationally acclaimed investor rights law firm, is
investigating potential securities fraud claims on behalf of
shareholders of AbbVie Inc. ("AbbVie" or the "Company")
(NYSE: ABBV) resulting from allegations that AbbVie and/or its
executives may have issued materially misleading business
information to the investing public.
If you purchased AbbVie securities, and/or would like to discuss
your legal rights and options, please visit AbbVie Shareholder
Investigation or contact Daniel
Sadeh toll free at (877) 779-1414 or
dsadeh@bernlieb.com.
On September 18, 2018,
Bloomberg reported that "California's insurance regulator is
suing AbbVie Inc., alleging that the pharmaceutical giant gave
illegal kickbacks to health-care providers in order to keep
patients on its blockbuster rheumatoid arthritis drug Humira." The
report further stated that, according to the California Department
of Insurance, "[t]he company 'engaged in a far-reaching scheme
including both classic kickbacks -- cash, meals, drinks, gifts,
trips, and patient referrals -- and more sophisticated ones -- free
and valuable professional goods and services to physicians to
induce and reward Humira prescriptions.'"
On this news, AbbVie stock fell $4.35 per share, or over 4.5%, over two
consecutive trading days to close at $91.02 per share on September 19, 2018, damaging investors.
If you purchased AbbVie securities, and/or would like to discuss
your legal rights and options, please visit
https://www.bernlieb.com/cases/abbvie-inc-abbv-lawsuit-class-action-fraud-stock-84/
or contact Daniel Sadeh toll free at
(877) 779-1414 or dsadeh@bernlieb.com.
Since 1993, Bernstein Liebhard LLP has recovered over
$3.5 billion for its clients. In
addition to representing individual investors, the Firm has been
retained by some of the largest public and private pension funds in
the country to monitor their assets and pursue litigation on their
behalf. As a result of its success litigating hundreds of lawsuits
and class actions, the Firm has been named to The National Law
Journal's "Plaintiffs' Hot List" thirteen times and listed in
The Legal 500 for ten consecutive years.
ATTORNEY ADVERTISING. © 2018 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Daniel Sadeh
Bernstein Liebhard LLP
http://www.bernlieb.com
(877) 779-1414
dsadeh@bernlieb.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/abbvie-investigation-bernstein-liebhard-llp-announces-investigation-of-abbvie-inc---abbv-300716344.html
SOURCE Bernstein Liebhard LLP